Monte Rosa Therapeutics, Inc. (GLUE)
13.38
-0.94
(-6.56%)
USD |
NASDAQ |
Aug 28, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics 30-Day Average Daily Volume : 1.353M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.353M |
| August 27, 2026 | 1.364M |
| August 26, 2026 | 1.366M |
| August 25, 2026 | 1.361M |
| August 24, 2026 | 1.363M |
| August 21, 2026 | 1.349M |
| August 20, 2026 | 1.374M |
| August 19, 2026 | 1.380M |
| August 18, 2026 | 1.404M |
| August 17, 2026 | 1.409M |
| August 14, 2026 | 1.415M |
| August 13, 2026 | 1.445M |
| August 12, 2026 | 1.468M |
| August 11, 2026 | 1.519M |
| August 10, 2026 | 1.557M |
| August 07, 2026 | 1.727M |
| August 06, 2026 | 1.751M |
| August 05, 2026 | 1.792M |
| August 04, 2026 | 1.784M |
| August 03, 2026 | 1.750M |
| July 31, 2026 | 1.756M |
| July 30, 2026 | 1.547M |
| July 29, 2026 | 1.517M |
| July 28, 2026 | 1.501M |
| July 27, 2026 | 1.493M |
| Date | Value |
|---|---|
| July 24, 2026 | 1.502M |
| July 23, 2026 | 1.502M |
| July 22, 2026 | 1.508M |
| July 21, 2026 | 1.551M |
| July 20, 2026 | 1.557M |
| July 17, 2026 | 1.552M |
| July 16, 2026 | 1.541M |
| July 15, 2026 | 1.535M |
| July 14, 2026 | 1.540M |
| July 13, 2026 | 1.544M |
| July 10, 2026 | 1.531M |
| July 09, 2026 | 1.493M |
| July 08, 2026 | 1.476M |
| July 07, 2026 | 1.447M |
| July 06, 2026 | 1.429M |
| July 02, 2026 | 1.426M |
| July 01, 2026 | 1.401M |
| June 30, 2026 | 1.377M |
| June 29, 2026 | 1.330M |
| June 26, 2026 | 1.286M |
| June 25, 2026 | 1.113M |
| June 24, 2026 | 1.072M |
| June 23, 2026 | 1.030M |
| June 22, 2026 | 989988.5 |
| June 18, 2026 | 952344.2 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Nurix Therapeutics, Inc. | 1.075M |
| Gilead Sciences, Inc. | 6.292M |
| Ironwood Pharmaceuticals, Inc. | 1.970M |
| Capricor Therapeutics, Inc. | 10.83M |
| Cue Biopharma, Inc. | 195527.5 |